abstract |
The present invention is directed towards a novel crystalline form of olmesartan medoxomil, to methods for preparing the compound, to compositionscomprising the compound, and to the use of said compound and compositions for the treatment or prevention of an angiotensin II receptor mediated disorder, in particular hypertension. |